Supplementary Methods
The use of "deg" after a residue denotes the use of degenerate primers to generate multiple mutants in one round of mutagenesis Red: Decrease in activity (1.5-fold change or more in the negative direction) Black: Neutral (-1.5 to 1.5-fold change) Green: Increase in activity (1.5-fold change or more in the positive direction)
Supplementary Table 1 . Fold change in hydrolytic activity on the PQ motif of all designed mutants, relative to KumaWT, when tested in crude cell lysate. The fold change in activity of hydrolysis of the fluorescently quenched α-gliadin hexapeptide (FQ) analogue for all of the tested mutants, relative to KumaWT, was calculated by dividing the measured activity of each mutant (in arbitrary fluorescence units per unit time) by the measured activity of KumaWT. In cases where the fold-change was less than one, e.g. 0.5 representing a two-fold drop in activity, the negative reciprocal was taken and reported as a negative fold-change from the wild type, e.g.
-2 for a two-fold drop in activity. The maximum fold-change among the multiple colonies tested for each variant is reported. Table 2 . Fold change in hydrolytic activity on the PQ motif of all purified and sequenced mutants, relative to KumaWT. Shown are the fold changes relative to KumaWT (calculated as described in Supp Table 1 ) for all mutants that were purified, sequenced, and assayed for activity against the FQ substrate. The assay was performed at pH 4, with enzyme final concentration of 0.0125 mg mL -1 and substrate concentration of 5 μM.
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Supplementary Figure 1 . Fold change in hydrolytic activity on the PQ motif of all designed mutants, relative to KumaWT. Shown is a graphical representation of the data presented in Supplementary Table 1 . Fold change was calculated by dividing the rate of hydrolysis of the fluorescent substrate of the mutant enzymes by the rate of KumaWT. When the fold change was less than one, the negative reciprocal was taken as described in Supp Table 1 . Only 20% of variants showed a decrease in activity, while 30% showed approximately equal activity to KumaWT, and 50% showed an increase in hydrolysis over KumaWT. To ensure that the lack of breakdown of substrates by SC PEP at pH 4 was due to inactivity at low pH rather than to inaccurately prepared enzyme, we tested the ability of SC PEP to digest a pNA labeled QP substrate at pH 7. SC PEP demonstrated the predicted catalytic activity on the QP substrate when tested at neutral pH, thus inaction of SC PEP at low pH is most likely due to the low capacity for catalysis at low pH for this enzyme, and not due to an error in purification or in preparation of SC PEP. The curve was fit using non-linear regression. m1 corresponds to k cat (s In order to correlate fluorescence intensity with the amount of fluorescent FQ product generated, we measured the fluorescence intensity of increasing levels of product in the presence of substrate at the initial concentrations used to determine protease catalytic activity. Intermolecular quenching is visible at higher levels of substrate, which causes a decrease in fluorescence intensity as substrate concentration increases.
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Supplementary Figure 8. Standard product curve for p-nitroaniline labeled peptides.
Shown are absorbance measurements at 385 nm (maximum absorbance) for varying concentrations of p-nitroaniline at both pH 4 and pH 7, in order to correlate absorbance of cleaved p-nitroaniline-labeled reporter peptides to product concentration at both pH levels. with gliadin representing approximately 30% of that protein 2 . Given that the molecular weight of α9-gliadin is approximately 30 kDa 2 , and the volume of an average male human stomach is approximately 1.5L 3 , we were able to calculate the rough concentration of α-gliadin in the stomach after ingestion of one slice of bread.
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In order to account for the α-gliadin being cleaved into approximately 20 smaller peptides, we used a 20-fold higher concentration of α9-gliadin peptide (500 mM) in our assay. By using a 1:10 enzyme to peptide molar ratio, we achieve a pill size of approximately 430 mg, roughly the size of two standard ibuprofen pills.
Enzyme Mutagenesis and Screening Method
Site directed mutagenesis was performed on KumaWT according to the protocol developed by Kunkel 4 . Four independent single colonies (or 4-fold the number of expected mutations if using a degenerate oligo) were isolated from agar plates and used to start cultures in 0.5 mL Luria Broth (LB) in 2 mL 96-deep-well plates with 50 μg mL -1 kanamycin. Plates were incubated with shaking at 1,250 rpm at 37°C for 16-24 hours. We used 20 μL of overnight to inoculate 1 mL of Terrific Broth (TB) with 50 μg ml -1 kanamycin and allowed to incubate for 2.5
hours at 37°C with shaking at 1,250 rpm. After 2.5 hours, production of the enzyme variants was induced with 50 μL of 10 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and transferred to an 18°C shaker for 24 hours. Cells were harvested by centrifugation at 2900*g for 20 min and the supernatant decanted. Cells were resuspended in 250 μL of lysis buffer that was composed of 1% 100X Triton, 1 mg mL -1 lysozyme, and 0.5 mg mL -1 DNase in a phosphate buffered saline solution (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 , at pH 7.4). Whole cell lysate was then centrifuged at 2900*g for 20 minutes and the supernatant was adjusted to pH 4 with 100 mM sodium acetate buffer. The clarified lysate was then screened for enzymatic activity against the FQ substrate by adding 10 μL of supernatant to 90 μL of 5 μM substrate in a 96-well black plate, and the fluorescence was measured at 30-second intervals for
Protein Expression and Purification
The genes encoding each protein of interest were transformed into E. coli BL21 (DE3) cells. Individual colonies were picked, inoculated into TB with 50 μg μL -1 kanamycin, and incubated overnight at 37°C. 500 mL of the overnight culture was added to 500 mL autoinduction media 5 and shaken at 37°C at 250 rpm for roughly 4 hours, after which the temperature was adjusted to 18°C and the cultures continued to incubate for 30 hours. Cells were harvested by centrifuging the culture at 4000 rpm for 20 minutes. Cell pellets were resuspended in 10 mL of PBS, then lysed via sonication with 5 mL lysis buffer (50 mM HEPES, 500 mM NaCl, 1 mM b-mercaptoethanol, 2 mg mL -1 lysozyme, 0.2 mg mL -1 DNase), and the insoluble matter was removed by spinning at 20,000 rpm for 30 minutes. Soluble protein in the supernatant was then purified over 1 mL TALON cobalt affinity columns. KumaMax, KumaWT, and SC PEP were washed three times with 20 mL wash buffer (10 mM imidazole, 50 mM HEPES, 500 mM NaCl, 1 mM bME), and then eluted in 15 mL of elution buffer (200 mM imidazole, 50 mM HEPES, 500 mM NaCl, 1 mM bME). EP-B2 was purified from the insoluble fraction after cell lysis, which was resuspended in 10 mL of EP-B2 Buffer (6M GuHCl, 10 mM imidazole, 50 mM HEPES, 500 mM NaCl, and 1 mM bME). Centrifugation at 20,000 rpm pelleted the remaining insoluble fraction, and the solubilized fraction of the pellet, containing denatured EP-B2, was filtered with a 0.8 μm filter onto the TALON column. EP-B2 was washed once with 20 mL of the EP-B2 buffer, before being washed twice with 20 mL of the standard wash buffer (non-denaturing) to refold the protein on the column. Protein was eluted with 15 mL of the standard elution buffer. All proteins were concentrated from 15 mL down to roughly 500 mL, then dialyzed against 1 L of dialysis buffer (20% glycerol, 50 mM HEPES, 500 mM NaCl, 1 mM bME 
